<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04971434</url>
  </required_header>
  <id_info>
    <org_study_id>P.T.REC/012/003251</org_study_id>
    <nct_id>NCT04971434</nct_id>
  </id_info>
  <brief_title>Fatty Liver Response of Cardio-metabolic Risk Factors to Laser Acupuncture Versus Cupping</brief_title>
  <official_title>Non-alcoholic Fatty Liver Response of Cardio-metabolic Risk Factors to Laser Acupuncture Versus Cupping-with-scarification</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Every-two-week applied cupping (with scarification) session within one month on back of upper&#xD;
      thorax is not compared previously regarding its effect on cardio-metabolic risk factors to&#xD;
      the daily application of laser on acupoints (for month, except Fridays) in fatty liver&#xD;
      patients. This trial will compare the two procedure effects on cardio-metabolic risk factors&#xD;
      in fatty liver.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In fatty liver patients,every-two-week applied cupping (with scarification) session within&#xD;
      one month on back of upper thorax for 30 patients will be compared regarding its effect on&#xD;
      cardio-metabolic risk factors to the daily application of laser on acupoints (for month,&#xD;
      except Fridays) of other 30 patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 11, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>high-density lipoprotein</measure>
    <time_frame>It will be measured after 4 weeks of treatment</time_frame>
    <description>serum lipid</description>
  </primary_outcome>
  <primary_outcome>
    <measure>low-density lipoprotein</measure>
    <time_frame>It will be measured after 4 weeks of treatment</time_frame>
    <description>serum lipid</description>
  </primary_outcome>
  <primary_outcome>
    <measure>cholesterol</measure>
    <time_frame>It will be measured after 4 weeks of treatment</time_frame>
    <description>serum lipid</description>
  </primary_outcome>
  <primary_outcome>
    <measure>triglyceride</measure>
    <time_frame>It will be measured after 4 weeks of treatment</time_frame>
    <description>serum lipid</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>c reactive protein</measure>
    <time_frame>It will be measured after 4 weeks of treatment</time_frame>
    <description>it will be measured in plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood glucose</measure>
    <time_frame>It will be measured after 4 weeks of treatment</time_frame>
    <description>fasting gluocse</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood pressure</measure>
    <time_frame>It will be measured after 4 weeks of treatment</time_frame>
    <description>it will be measure with manual manometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rate of pulse</measure>
    <time_frame>It will be measured after 4 weeks of treatment</time_frame>
    <description>it will be measured at radial artery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Fatty Liver</condition>
  <arm_group>
    <arm_group_label>laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In fatty liver patients (30 patients), a daily application of 4-minute laser (for one month, except Fridays) on acupoint number 25,40,36 of stomach meridian, acupoint number 3 of liver meridian, acupoint number 6 of spleen meridian,acupoint number 9.12,4 of conception vessel meridian, acupoint number 14 of governor vessel meridian, acupoint number 4, 11 of large intestine meridian, acupoint number 34 of gall bladder meridian</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cupping with scarification</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In fatty liver patients (30 patients),every-two-week applied cupping (with scarification) session within one month on back of upper thorax</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>laser stimulation for acupoints</intervention_name>
    <description>In fatty liver patients (30 patients), a daily application of 4-minute laser (for one month, except Fridays) on acupoint number 25,40,36 of stomach meridian, acupoint number 3 of liver meridian, acupoint number 6 of spleen meridian,acupoint number 9,12,4 of conception vessel meridian, acupoint number 14 of governor vessel meridian, acupoint number 4, 11 of large intestine meridian, acupoint number 34 of gall bladder meridian</description>
    <arm_group_label>laser</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>cupping with scarification</intervention_name>
    <description>In fatty liver patients (30 patients),every-two-week applied cupping (with scarification) session within one month on back of upper thorax</description>
    <arm_group_label>cupping with scarification</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosed Fatty liver patients by ultrasonography&#xD;
&#xD;
          -  Class I obese patients&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cardiovascular and respiratory disorders/diseases.&#xD;
&#xD;
          -  Autoimmune disorders/diseases.&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Other liver disorders/diseases.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>self-representation of gender identity.</gender_description>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ali Ismail, lecturer</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ali Ismail, lecturer</last_name>
    <phone>02 01005154209</phone>
    <email>allooka2012@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Physical Therapy Cairo University</name>
      <address>
        <city>Giza</city>
        <state>Dokki</state>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ali Ismail, lecturer</last_name>
      <phone>02 01005154209</phone>
      <email>allooka2012@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 11, 2021</study_first_submitted>
  <study_first_submitted_qc>July 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2021</study_first_posted>
  <last_update_submitted>July 12, 2021</last_update_submitted>
  <last_update_submitted_qc>July 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Ali Mohamed Ali ismail</investigator_full_name>
    <investigator_title>lecturer of Physical Therapy for Cardiovascular / Respiratory Disorder and Geriatrics, Faculty of Physical Therapy, Cairo University</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatty Liver</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

